AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimbeat MV 1mg/500mg/0.1mg Tablet

Prescription Icon
Prescription Required

Marketer

Brivan Biotech Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.1mg)

Overview Glimbeat MV 1mg/500mg/0.1mg Tablet

Diabetic patients (adults) can manage type 2 diabetes mellitus with Glimbeat MV 1mg/500mg/0.1mg, an anti-diabetic combination tablet. This medication regulates blood glucose, administered with meals consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision loss, neuropathy, and limb amputation. This medication complements a comprehensive treatment plan encompassing a healthy diet, regular physical activity, and weight management as advised by your doctor. Lifestyle choices are key to diabetes control. Hypoglycemia (low blood sugar) is a common side effect, manifesting as sweating, dizziness, headaches, and tremors. Recognize these symptoms and carry a quick-acting glucose source (e.g., sugary snacks, juice). Alcohol consumption elevates hypoglycemia risk and should be avoided. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headaches, edema, blurred vision, fractures, and upper respiratory infections; weight gain is also possible. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart conditions require physician consultation before initiating treatment. Pregnant or nursing individuals should seek medical advice. Regular blood glucose checks, along with blood tests monitoring blood cell counts and liver function, are essential.

Primary Ingredients of Glimbeat MV 1mg/500mg/0.1mg Tablet

No text provided. Please provide the text you want me to rephrase.

Uses of Glimbeat MV 1mg/500mg/0.1mg Tablet

Managing Type 2 Diabetes

Major Benefits of Glimbeat MV 1mg/500mg/0.1mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Glimbeat MV 1mg/500mg/0.1mg tablets on an empty stomach.

Common Side effects of Glimbeat MV 1mg/500mg/0.1mg Tablet:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Glimbeat MV 1mg/500mg/0.1mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Glimbeat MV 1mg/500mg/0.1mg Tablet on an empty stomach.

How Glimbeat MV 1mg/500mg/0.1mg Tablet works:

Tri-therapy antidiabetic tablet, Glimbeat MV, contains 1mg, 500mg, and 0.1mg of three distinct medications.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimbeat MV 1mg/500mg/0.1mg Tablet with alcohol is hazardous.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimbeat MV 1mg/500mg/0.1mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible risks prior to prescribing. Seek medical advice before taking this medication.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Glimbeat MV 1mg/500mg/0.1mg tablets while breastfeeding is likely inadvisable. Available data from human studies indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyUNSAFE

The use of Glimbeat MV 1mg/500mg/0.1mg tablets is likely unsafe for individuals with kidney impairment and should be omitted. Medical advice is essential. Furthermore, this medication is unsuitable for patients experiencing severe kidney dysfunction.

LiverLiverCAUTION

Patients with liver impairment should use Glimbeat MV 1mg/500mg/0.1mg Tablets cautiously, potentially requiring dosage modification. Medical advice is recommended. A reduced initial dose is typically prescribed for individuals with mild to moderate liver disease; however, this medication is unsuitable for those with severe hepatic dysfunction.

What if you forget to take Glimbeat MV 1mg/500mg/0.1mg Tablet :

Should you forget to take a Glimbeat MV 1mg/500mg/0.1mg Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimbeat MV 1mg/500mg/0.1mg Tablet

LabelValue
Potential for Dependence None.
Medication Classification Medication for diabetes

FAQs on Glimbeat MV 1mg/500mg/0.1mg Tablet

Glimepiride, Metformin, and Voglibose, combined as Glimbeat MV 1mg/500mg/0.1mg Tablet, treat type 2 diabetes mellitus. This medication helps regulate blood sugar in adults when used with a healthy diet and exercise. Glimepiride stimulates insulin release from the pancreas, thus reducing blood glucose. Metformin reduces liver glucose production and enhances insulin effectiveness. Voglibose, an alpha-glucosidase inhibitor, decreases postprandial glucose levels. This triple therapy is unsuitable for type 1 diabetes management.
Taking Glimbeat MV 1mg/500mg/0.1mg tablets may cause common side effects including low blood sugar, nausea, diarrhea, changes in taste perception, gas, abdominal pain, headache, skin reactions, and respiratory infections.
Patients with hypersensitivity to any Glimbeat MV 1mg/500mg/0.1mg Tablet constituent or inactive ingredient should not take this medication. Its use is contraindicated in individuals with moderate to severe renal impairment, inflammatory bowel conditions, colonic ulcers, and metabolic acidosis, including diabetic ketoacidosis.
Combining Glimbeat MV 1mg/500mg/0.1mg tablets and alcohol is unsafe. This combination risks dangerously low blood sugar (hypoglycemia) and heightened lactic acidosis probability.
Indeed, Glimbeat MV 1mg/500mg/0.1mg Tablets can induce hypoglycemia. Low blood sugar manifests as nausea, headache, irritability, hunger, sweating, dizziness, tachycardia, and anxiety or tremors. The risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. Carrying readily available glucose sources, such as glucose tablets, honey, or fruit juice, is recommended.
Retain this medication within its original, sealed packaging. Follow the storage guidelines provided on the product's label or packaging. Discard any remaining medication. Ensure it remains inaccessible to children, animals, and others.
Glimbeat MV 1mg/500mg/0.1...
66
MRP 80
17% off